By aligning internal operations with outsourced processes and offering hands-on QA management support, we ensured a smooth, compliant, and practical implementation
About this Case Study
This case study highlights how Rephine supported a fast-growing biotech company specialising in novel cancer biotherapeutics as it prepared to enter non-clinical and clinical trial phases. The company, recently spun out from two institutions, needed to establish a fully GMP-compliant Quality Management System (QMS) to support its Investigational Medicinal Product (IMP) operations.
Facing challenges such as a lack of internal GMP knowledge and key roles being managed by external consultants, the company required a flexible yet robust QMS tailored to its structure and regulatory needs. Rephine delivered a scalable system, embedded QA oversight, and ensured alignment across internal teams and outsourced partners—achieving full GxP readiness and preparing the client for regulatory inspections.
Download the full case study now and discover how Rephine helped a biotech company achieve GMP compliance for their IMP operations.
Download the Case Study
View other our other resources and company news
Blog Supplier Qualification in GxP Compliance: Strengthening Pharmaceutical Supply Chains
Blog How Data Integrity Audits Prevent Compliance Failures
Blog Best Practices in Cleaning Validation for GMP Compliance
Case Study GMP Compliance for API Manufacturing: Requalifying a Fire-Damaged Plant
Blog Understanding FDA Quality Metrics: Preparing for Compliance and Competitive Advantage
Blog Risk Management in GMP: Best Practices for Compliance
Case Study Building a QMS for IMP Operations to Ensure GMP Compliance
Blog How to Build a QMS for IMP Operations and Achieve GMP Compliance
Blog